TOST Quantitative Stock Analysis

Validea's guru fundamental report rates TOAST INC (TOST), a large-cap software growth stock, at 66% using Partha Mohanram's P/B Growth Investor model, which identifies low book-to-market stocks with sustained growth potential. While TOST passed several key financial health criteria like return on assets and cash flow, it failed on sales variance, advertising to assets, and capital expenditures to assets, placing its overall score below the model's typical interest threshold of 80%.

Analysis

Toast, Inc. (TOST) scores a 66% rating based on Validea's interpretation of Partha Mohanram's P/B Growth Investor model, a framework designed to identify low book-to-market stocks with indicators of sustained growth. This score is notably below the 80% threshold that typically signals model interest, reflecting a mixed fundamental picture. On the positive side, TOST passes criteria related to its valuation (Book/Market Ratio), profitability (Return on Assets), and cash generation (Cash Flow from Operations to Assets). It also demonstrates stable profitability (ROA Variance) and investment in innovation (Research and Development to Assets). However, the model has flagged significant concerns, as indicated by failures in three key areas: Sales Variance, Advertising to Assets, and Capital Expenditures to Assets. These failures suggest potential inconsistencies in revenue growth and a spending profile on marketing and capex that may not align with the model's criteria for sustainable, efficient growth. The mildly negative sentiment score of -0.2 for TOST corroborates this lukewarm assessment, positioning the stock as having some positive financial health attributes but failing to meet the specific requirements of a high-conviction growth investment under this particular quantitative screen.

Key Decisions for Investors

• Given TOST's 66% score is below the model's 80% interest threshold, investors adhering to quantitative growth strategies should view this as a signal of caution, as the stock does not meet the full criteria of this academically-backed screen.
• Investors should conduct further due diligence on the specific areas of failure, particularly sales variance, advertising spending efficiency, and capital expenditure levels, to understand if these represent transient issues or long-term structural weaknesses.
• While the report flags notable risks, the passing grades on core health metrics like Return on Assets and Cash Flow suggest the company has underlying strengths, which should be weighed against the identified inconsistencies for a balanced investment thesis.